IMAX stock holds Buy rating with $36 target from Texas Capital

On Wednesday, Texas Capital Securities maintained a Buy rating on IMAX Corporation (NYSE:IMAX) with a steady price target of $36.00, aligning with the broader analyst consensus that shows targets ranging from $16 to $35. According to InvestingPro data, IMAX is currently trading at a P/E ratio of 44.9x, suggesting high growth expectations. This confirmation comes amidst concerns regarding the potential impact of the Chinese government's consideration to ban Hollywood film imports in response to tariffs imposed by the Trump Administration. The ban was suggested as a possible retaliation measure, as reported on Tuesday.

IMAX management has indicated that there have been no changes in the guidance or orders regarding upcoming releases from the China Film Bureau. With a strong current ratio of 3.92 and moderate debt levels, IMAX appears well-positioned to weather potential market disruptions. Analysts at Texas Capital Securities believe that such a ban on Hollywood films is unlikely due to the Chinese government's recent efforts to boost the country's economy and the significant role Hollywood films play within it.

Furthermore, Texas Capital Securities suggests that IMAX is better protected against such measures than some might expect. This resilience is attributed to IMAX's ability to showcase local language content, which could mitigate the impact of any restrictions on Hollywood films.

The analyst's commentary pointed out that the roughly 8% decline in IMAX shares on Tuesday, which was more significant than the approximately 3% drop in the Russell 2000 index, was an overreaction to the media report. The firm reasserted its Buy rating and price target for IMAX, signaling confidence in the company's position and prospects despite the rumors of regulatory challenges in China.

In other recent news, IMAX Corporation reported its fourth-quarter earnings for 2024, revealing a significant shortfall as both earnings per share and revenue missed analyst forecasts. The company posted an EPS of $0.27, falling short of the expected $0.42, and revenue came in at $92.7 million against a forecast of $118.33 million. Despite this, IMAX experienced an 8% year-over-year growth in quarterly revenue and a 21% improvement in operating cash flows. Meanwhile, the company has announced an expansion of its partnership with TOHO Cinemas in Japan, planning to open six new IMAX with Laser systems by 2026, further strengthening its presence in the region.

In addition, Kinepolis Group is set to nearly double its IMAX locations across Europe, the United States, and Canada, with nine new venues planned. Analyst firms have expressed mixed sentiments about IMAX's future; Benchmark maintained a Buy rating with a $30 price target, citing concerns over cost management, while Rosenblatt Securities raised its price target to $35, highlighting a strong start to the first quarter. The release of films like "Captain America: Brave New World" and "Ne Zha 2" has contributed to a positive turnaround, with the latter grossing over $1.3 billion globally, including more than $100 million in IMAX theaters alone.

IMAX's strategic initiatives include a focus on its direct-to-consumer segment and new product launches, such as Tetris and sweepstakes, which are seen as critical growth opportunities. The company has also entered into a groundbreaking deal with Netflix (NASDAQ:NFLX) for the exclusive IMAX release of Greta Gerwig's "Narnia," showcasing its leverage in the market. These developments indicate a dynamic period for IMAX, as it continues to expand its global footprint and enhance its technological offerings.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.